IRIS
BARSOTTI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.318
Totale 9.318
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.318
Totale 9.318
Salva come PNG Salva come JPEG
Città #
Genova 6.503
Rapallo 1.228
Genoa 832
Vado Ligure 725
Bordighera 30
Totale 9.318
Salva come PNG Salva come JPEG
Nome #
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 166
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. 154
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 151
ACE inhibitors can induce circulating antibodies directed to antigens of the superficial epidermal cells. 144
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 141
Increased neutrophil lifespan in patients with congestive heart failure. 137
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 137
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 131
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 131
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 130
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. 128
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 128
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 127
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 126
Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy. 123
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 122
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 120
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 117
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 116
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy 115
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 114
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 114
MR EVALUATION OF CORONARY STENTS WITH NAVIGATOR ECHO AND BREATH-HOLD CINE GRADIENT-ECHO TECHNIQUES 113
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 111
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 110
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 110
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 108
OxLDL- and HSP-60 antigen-specific CD8(+) T lymphocytes are detectable in the peripheral blood of patients suffering from coronary artery disease. 107
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 104
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 102
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 102
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 101
Associazione tra lipoperossidazione ed insorgenza giovanile di aterosclerosi coronarica. 101
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 100
Early Age of onset of unstable angina is associated to major oxidative stress 99
Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. 98
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 98
N-acetyl-cysteine Regulates the Response to Injury in NZW Rabbit Aorta. 97
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities 96
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 95
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 94
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 94
PROGENITOR CD34+ CELLS AND CIRCULATING ENDOTHELIAL CELLS IN PATIENTS WITH ACUTE OR CHRONIC HEART FAILURE 94
Biliopancreatic diversion reduces QT interval and dispersion in morbidly obese patients 94
Cor triatratum sinistrum and persistent left superior vena cava: an original association. 92
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 92
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 91
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 91
Improved assessment of left ventricular volumes and ejection fraction by contrast enhanced harmonic color Doppler echocardiography 91
LA DOXORUBICINA ALTERA L’ESPRESSIONE DELL’IGF-1R E DELL’IGFBP3 IN CELLULE MUSCOLARI CARDIACHE. UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ 91
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 89
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 89
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 88
Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy 85
Osteopontin plasma levels correlate with coronary atherosclerosis extension and in-stent restenosis in coronary artery disease patients undergoing percutaneous coronary intervention 83
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 83
Coronary aneurysms and stenosis detected with magnetic resonance coronary angiography in a patient with Kawasaki disease. 81
Accuracy of noninvasive monitoring of coronary flow velocity reserve with transthoracic echo-doppler in detecting coronary restenosis after successfull coronary angioplasty: a multicenter study 80
ALTERAZIONI DELLE PROTEINE TELOMERICHE E SENESCENZA: UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ DA ANTRACICLINE 80
Thrombus determinants of vascular cell activation. 80
Transcatheter occlusion of PFO and ASD in cryptogenic stroke 79
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 78
Oxidative stress, apoptosis and immunological activation in acute myocardial infarction 77
Early age of onset of unstable angina is associated with major oxidative stress 76
Relazione tra Stress Parietale e Risposta Infiammatoria Sistemica con Danno Miocardico in pazienti con Insufficienza Cardiaca Cronica in fase Stabile 75
A PATHOGENETIC HYPOTHESIS ABOUT ELECTRIC STORM. 75
Doxorubicin induces activation of Metalloproteinase-2 and –9 in cardiomyocytes through the MAPKinase pathways: protective effects of carvedilol and dexrazoxane 75
Markers of oxidative stress evaluated in patients with ischemic heart disease at the time of their first clinical manifestation. 74
Traditional risk factors for ATS do not explain major oxidative stress levels in patients with early age onset of unstable angina: possibile role for genetic factors? Population genetics of haemostatic risk factors for arterial vascular disease. 73
Il carvedilolo protegge le cellule endoteliali contro la produzione di radicali liberi e l’apoptosi indotte da doxorubicina. 73
Time-course of acute myocardial infarction-dependent peripheral mobilisation of endothelial progenitor cells 72
Dispersione del QT in Soggetti con Insufficienza Renale Cronica Trattati con Dialisi Peritoneale o con Emodialisi. 71
IL SIERO POSTPRANDIALE MOSTRA EFFETTI PRO-OSSIDANTI E PROAPOPTOTICI SULLE CELLULE ENDOTELIALI 70
STRESS OSSIDATIVO E P53 MEDIANO L’INIBIZIONE DI IGF-1R INDOTTA DA DOXORUBICINA IN CELLULE MUSCOLARI CARDIACHE 69
Myocardial magnetic resonance spectroscopy 69
Prevalence of persistent left superior vena cava and its implication in pacemaker implantation 68
Evaluation of Xa/Va activity bound to platelet-rich thrombi in patients with acute coronary syndromes 68
Il carvedilolo previene la formazione di radicali liberi e il danno ossidativo indotto da doxorubicina sui cardiomiociti. 67
Insorgenza precoce di angina instabile e livelli plasmatici di perossidazione lipidica 66
Un pasto iperlipidico rende il siero pro-apoptotico per le cellule endoteliali: ruolo dell’infiammazione e stress ossidativo. 66
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study 66
La doxorubicina induce apoptosi e senescenza nei progenitori delle cellule endoteliali e regola l'azione chemiotattica dei cardiomiociti nei loro confronti 66
TRATTAMENTI SEQUENZIALI CON DOSI SUB-APOPTOTICHE DI EPIDOXORUBICINA ED ANTICORPO ANTI erbB2 INDUCONO APOPTOSI NEI CARDIOMIOCITI: RUOLO CARDIOPROTETTIVO DEL DEXRAZOXANE. 65
Up-regulation of lectin-like oxidised LDL receptor-1 (LOX-1) in cardiac muscle cells and implications in doxorubicin-induced cardiotoxicity. 65
Elevata attivita’ di metalloprteasi 2 e 9 circolanti nei pazienti con scompenso cardiaco 64
Il carvedilolo previene la perdita del potenziale di membrana mitocondriale indotta da doxorubicina nei cardiomiociti 63
Meccanismi di tossicità indotta da doxorubicina su cardiomiociti e razionale per l’uso dei farmaci protettivi nella pervenzione del danno cardiaco 62
Doxorubicin induces LOX-1 expression in cardiac myocytes via oxidative stress: role of cardioprotective agents 62
Neutrophil-derived matrix metalloproteinase 9 is increased in patients with heart failure 62
Pazienti con manifestazione precoce di angina instabile non presentano correlazioni tra livelli di stress ossidativo e autoanticorpi diretti contro proteine ossidate. 62
Ruolo del Polimorfismo C242T della Subunità p22phox del Complesso NAD(P)H Ossidasi in Pazienti con Aterosclerosi Coronarica. 62
La doxorubicina induce le metalloproteasi 2 e –9 attraverso l’attivazione delle MAPK: ruolo protettivo del carvedilolo e del dexrazoxane., 61
Mobilizzazione ematica di sottopopolazioni di progenitori di cellule endoteliali in pazienti con infarto acuto del miocardio 55
Involvement of neutrophils and of C-C chemokines in chronic heart failure 54
La doxorubicina induce l’aumento della trascrizione e dell’attività della MMP-2 nelle cellule muscolari cardiache attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 54
Polimorfismo nel gene cyba: possibile marcatore di suscettibilita’ genetica all’aterosclerosi 53
La doxorubicina induce l’espressione di LOX-1R in cellule muscolari cardiache attraverso un incremento dello stress ossidativo: ruolo di molecole cardioprotettive 53
SUBSET MONOCITARI CD14 CD16 IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO. 52
Effetto protettivo del carvedilolo contro la morte per apoptosi indotta da doxorubicina in cellule muscolari cardiache. 50
La metalloproteasi di tipo 9 proveniente dai neutrofili aumenta nei pazienti con scompenso cardiaco. 48
Totale 9.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.725
article - articoli 21.236
book - libri 0
conference - conferenze 4.489
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.575 0 0 0 0 0 206 298 87 160 456 264 104
2020/2021335 24 33 17 26 13 36 6 30 49 31 32 38
2021/20221.205 9 102 84 159 68 65 76 308 23 121 45 145
2022/20231.430 130 78 6 161 280 239 6 106 231 5 165 23
2023/2024598 23 83 10 54 52 129 37 37 59 7 32 75
2024/2025787 46 128 59 137 258 159 0 0 0 0 0 0
Totale 9.331